| scholarly article | Q13442814 |
| P50 | author | Paul Greengard | Q309979 |
| P2093 | author name string | R L Huganir | |
| G L Snyder | |||
| A A Fienberg | |||
| P2860 | cites work | Regulation of NMDA receptors in cultured hippocampal neurons by protein phosphatases 1 and 2A. | Q48122032 |
| Coadministration of MK-801 with amphetamine, cocaine or morphine prevents rather than transiently masks the development of behavioral sensitization | Q48267682 | ||
| Protein kinase C reduces Mg2+ block of NMDA-receptor channels as a mechanism of modulation | Q48493712 | ||
| Bidirectional regulation of DARPP-32 phosphorylation by dopamine. | Q48617260 | ||
| Phosphorylation-dependent regulation of N-methyl-D-aspartate receptors by calmodulin | Q48637162 | ||
| A postsynaptic interaction between dopamine D1 and NMDA receptors promotes presynaptic inhibition in the rat nucleus accumbens via adenosine release. | Q48658263 | ||
| DARPP-32, a dopamine- and adenosine 3':5'-monophosphate-regulated phosphoprotein enriched in dopamine-innervated brain regions. III. Immunocytochemical localization. | Q48691508 | ||
| Cyclic AMP-dependent protein kinase and protein kinase C phosphorylate N-methyl-D-aspartate receptors at different sites | Q48708894 | ||
| D1 receptor activation enhances evoked discharge in neostriatal medium spiny neurons by modulating an L-type Ca2+ conductance. | Q48723732 | ||
| Characterization of protein kinase A and protein kinase C phosphorylation of the N-methyl-D-aspartate receptor NR1 subunit using phosphorylation site-specific antibodies | Q48797328 | ||
| Addiction to cocaine and amphetamine | Q48983573 | ||
| Modulation of calcium currents by a D1 dopaminergic protein kinase/phosphatase cascade in rat neostriatal neurons | Q56568483 | ||
| Dopamine D1 receptor modulates the voltage-gated sodium current in rat striatal neurones through a protein kinase A | Q72300596 | ||
| DARPP-32: regulator of the efficacy of dopaminergic neurotransmission | Q23909380 | ||
| Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 | Q25938983 | ||
| Activation of NMDA receptors induces dephosphorylation of DARPP-32 in rat striatal slices | Q28236649 | ||
| DARPP-32, a dopamine-regulated neuronal phosphoprotein, is a potent inhibitor of protein phosphatase-1 | Q28259380 | ||
| Regulation of NMDA receptor phosphorylation by alternative splicing of the C-terminal domain | Q28259857 | ||
| Inactivation of NMDA receptors by direct interaction of calmodulin with the NR1 subunit | Q28278075 | ||
| A dopamine- and cyclic AMP-regulated phosphoprotein enriched in dopamine-innervated brain regions | Q28643908 | ||
| Mammalian brain phosphoproteins as substrates for calcineurin | Q28643957 | ||
| Drug abuse: hedonic homeostatic dysregulation | Q29615904 | ||
| Cloned glutamate receptors | Q29619950 | ||
| Molecular biology of dopamine receptors | Q35992691 | ||
| Neuromodulatory actions of dopamine in the neostriatum are dependent upon the excitatory amino acid receptor subtypes activated | Q36599964 | ||
| The phosphoprotein DARPP-32 mediates cAMP-dependent potentiation of striatal N-methyl-D-aspartate responses | Q36833070 | ||
| Dopamine receptor subtypes colocalize in rat striatonigral neurons | Q37270387 | ||
| Phosphorylated Mr 32,000 dopamine- and cAMP-regulated phosphoprotein inhibits Na+,K(+)-ATPase activity in renal tubule cells | Q37462899 | ||
| Amphetamine and dopamine-induced immediate early gene expression in striatal neurons depends on postsynaptic NMDA receptors and calcium. | Q38355902 | ||
| Molecular Mechanisms of Drug Reinforcement and Addiction | Q40441120 | ||
| Regulated subcellular distribution of the NR1 subunit of the NMDA receptor | Q41294276 | ||
| Sustained potentiation of NMDA receptor-mediated glutamate responses through activation of protein kinase C by a μ opioid | Q44335232 | ||
| Dopaminergic modulation of NMDA-induced whole cell currents in neostriatal neurons in slices: contribution of calcium conductances | Q46110140 | ||
| Dopamine and N-methyl-D-aspartate receptor interactions in the neostriatum | Q46717751 | ||
| Excitatory synaptic transmission in neostriatal neurons: regulation by cyclic AMP-dependent mechanisms | Q46969642 | ||
| P4510 | describes a project that uses | ImageQuant | Q112270642 |
| P433 | issue | 24 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | dopamine | Q170304 |
| P304 | page(s) | 10297-10303 | |
| P577 | publication date | 1998-12-01 | |
| P1433 | published in | Journal of Neuroscience | Q1709864 |
| P1476 | title | A dopamine/D1 receptor/protein kinase A/dopamine- and cAMP-regulated phosphoprotein (Mr 32 kDa)/protein phosphatase-1 pathway regulates dephosphorylation of the NMDA receptor | |
| P478 | volume | 18 |
| Q44158663 | A D2 class dopamine receptor transactivates a receptor tyrosine kinase to inhibit NMDA receptor transmission |
| Q34892958 | A role for casein kinase 1 epsilon in the locomotor stimulant response to methamphetamine. |
| Q36293916 | A scale-free systems theory of motivation and addiction |
| Q34536809 | Activation of D1/D5 dopamine receptors protects neurons from synapse dysfunction induced by amyloid-beta oligomers |
| Q48519315 | Activation of cyclic AMP-dependent protein kinase is required for long-term enhancement at corticostriatal synapses in rats |
| Q30488298 | Activation of dopamine D1 receptors blocks phencyclidine-induced neurotoxicity by enhancing N-methyl-D-aspartate receptor-mediated synaptic strength |
| Q28574586 | Activation of glycogen synthase kinase-3 beta is required for hyperdopamine and D2 receptor-mediated inhibition of synaptic NMDA receptor function in the rat prefrontal cortex |
| Q52162584 | Activity-dependent induction of tonic calcineurin activity mediates a rapid developmental downregulation of NMDA receptor currents. |
| Q34824112 | Adenosine A2A receptor contributes to ischemic brain damage in newborn piglet |
| Q47761863 | Adolescent stress leads to glutamatergic disturbance through dopaminergic abnormalities in the prefrontal cortex of genetically vulnerable mice. |
| Q48170248 | Altered Gene Expression Following Cardiopulmonary Bypass and Circulatory Arrest |
| Q37778900 | Assemblies of glutamate receptor subunits with post-synaptic density proteins and their alterations in Parkinson's disease |
| Q28508178 | Balanced NMDA receptor activity in dopamine D1 receptor (D1R)- and D2R-expressing medium spiny neurons is required for amphetamine sensitization |
| Q33703262 | Beyond the dopamine receptor: the DARPP-32/protein phosphatase-1 cascade |
| Q35678836 | Biochemical modulation of NMDA receptors: role in conditioned taste aversion |
| Q90464024 | Caffeine Accelerates Emergence from Isoflurane Anesthesia in Humans: A Randomized, Double-blind, Crossover Study |
| Q47280368 | Caffeine accelerates recovery from general anesthesia via multiple pathways |
| Q79073580 | Calcium signaling dysfunction in schizophrenia: a unifying approach |
| Q28392932 | Calcium-dependent inactivation of calcium channels in the medial striatum increases at eye opening |
| Q38024032 | Calcium-dependent networks in dopamine-glutamate interaction: the role of postsynaptic scaffolding proteins. |
| Q36757540 | Canadian Association of Neurosciences Review: the role of dopamine receptor function in neurodegenerative diseases. |
| Q42469910 | Cellular and subcellular distribution of spinophilin, a PP1 regulatory protein that bundles F-actin in dendritic spines |
| Q23914341 | Chronic dopaminergic signaling in the basal ganglia: a damage perspective on kinases and fos-related antigens |
| Q26741317 | Control of Appetite and Food Preference by NMDA Receptor and Its Co-Agonist d-Serine |
| Q38177261 | Convergence of dopamine and glutamate signaling onto striatal ERK activation in response to drugs of abuse. |
| Q44608458 | Coordinated PKA and PKC phosphorylation suppresses RXR-mediated ER retention and regulates the surface delivery of NMDA receptors |
| Q42177230 | Corticostriatal Plastic Changes in Experimental L-DOPA-Induced Dyskinesia |
| Q28594634 | Cyclin-dependent kinase 5 regulates dopaminergic and glutamatergic transmission in the striatum |
| Q28910380 | Cytosolic sulfotransferase 1A3 is induced by dopamine and protects neuronal cells from dopamine toxicity: role of D1 receptor-N-methyl-D-aspartate receptor coupling |
| Q73776363 | D(1) dopamine receptor activation reduces GABA(A) receptor currents in neostriatal neurons through a PKA/DARPP-32/PP1 signaling cascade |
| Q44067022 | D1 dopamine receptor regulation of microtubule-associated protein-2 phosphorylation in developing cerebral cortical neurons. |
| Q36962759 | D1/5 receptor-mediated enhancement of LTP requires PKA, Src family kinases, and NR2B-containing NMDARs |
| Q24564769 | D2-like receptors in nucleus accumbens negatively modulate acetylcholine release in prefrontal cortex |
| Q44030628 | DARPP-32 and regulation of the ethanol sensitivity of NMDA receptors in the nucleus accumbens |
| Q35639141 | DARPP-32: an integrator of neurotransmission |
| Q35106605 | Deciphering the Actions of Antiparkinsonian and Antipsychotic Drugs on cAMP/DARPP-32 Signaling |
| Q44770086 | Decreased phosphorylation of NMDA receptor type 1 at serine 897 in brains of patients with Schizophrenia. |
| Q73258728 | Degree of immediate early gene induction in striatum by eticlopride determines sensitivity to N-methyl-D-aspartate receptor blockade |
| Q37077042 | Developmental switch in requirement for PKA RIIbeta in NMDA-receptor-dependent synaptic plasticity at Schaffer collateral to CA1 pyramidal cell synapses |
| Q36980691 | Differential localization of protein phosphatase-1alpha, beta and gamma1 isoforms in primate prefrontal cortex |
| Q36191610 | Direct receptor cross-talk can mediate the modulation of excitatory and inhibitory neurotransmission by dopamine |
| Q42734818 | Dissecting the contribution of individual receptor subunits to the enhancement of N-methyl-d-aspartate currents by dopamine D1 receptor activation in striatum |
| Q48590755 | Distinct roles for spinophilin and neurabin in dopamine-mediated plasticity |
| Q33857187 | Dopamine D1 and N-methyl-D-aspartate receptors and extracellular signal-regulated kinase mediate neuronal morphological changes induced by repeated cocaine administration |
| Q43683702 | Dopamine D1 receptor-dependent trafficking of striatal NMDA glutamate receptors to the postsynaptic membrane. |
| Q30427606 | Dopamine D1 receptor-mediated inhibition of NADPH oxidase activity in human kidney cells occurs via protein kinase A-protein kinase C cross talk |
| Q34372253 | Dopamine D1 receptors mediate CREB phosphorylation via phosphorylation of the NMDA receptor at Ser897-NR1. |
| Q63256021 | Dopamine and cAMP-regulated phosphoprotein 32 kDa controls both striatal long-term depression and long-term potentiation, opposing forms of synaptic plasticity |
| Q37734563 | Dopamine and glutamate in Huntington's disease: A balancing act. |
| Q37633464 | Dopamine elevates and lowers astroglial Ca2+ through distinct pathways depending on local synaptic circuitry |
| Q28570233 | Dopamine enhancement of NMDA currents in dissociated medium-sized striatal neurons: role of D1 receptors and DARPP-32 |
| Q44306940 | Dopamine enhances EPSCs in layer II-III pyramidal neurons in rat prefrontal cortex. |
| Q36157445 | Dopamine receptor modulation of hypoxic-ischemic neuronal injury in striatum of newborn piglets. |
| Q38058009 | Dopamine receptor signaling and current and future antipsychotic drugs |
| Q41838215 | Dopamine receptors regulate NMDA receptor surface expression in prefrontal cortex neurons |
| Q42444141 | Dopamine-dependent long-term depression at subthalamo-nigral synapses is lost in experimental parkinsonism |
| Q44919590 | Dopamine-glutamate interactions controlling prefrontal cortical pyramidal cell excitability involve multiple signaling mechanisms. |
| Q34070883 | Dopamine-mediated regulation of striatal neuronal and network interactions |
| Q35184819 | Dopamine: a potential substrate for synaptic plasticity and memory mechanisms |
| Q28577705 | Dual regulation of NMDA receptor functions by direct protein-protein interactions with the dopamine D1 receptor |
| Q39041217 | Dysregulation of Corticostriatal Connectivity in Huntington's Disease: A Role for Dopamine Modulation |
| Q44268143 | Effect of amphetamine and phencyclidine on DNA-binding activities of serum response and dyad symmetry elements. |
| Q44626252 | Epilepsy, neurodegeneration, and extracellular glutamate in the hippocampus of awake and anesthetized rats treated with okadaic acid |
| Q36211455 | Existence and theoretical aspects of homomeric and heteromeric dopamine receptor complexes and their relevance for neurological diseases |
| Q35161675 | Forebrain striatal-specific expression of mutant huntingtin protein in vivo induces cell-autonomous age-dependent alterations in sensitivity to excitotoxicity and mitochondrial function. |
| Q29618488 | FoxP2 expression in avian vocal learners and non-learners |
| Q45015208 | GABAA receptor phospho-dependent modulation is regulated by phospholipase C-related inactive protein type 1, a novel protein phosphatase 1 anchoring protein. |
| Q34590422 | Glutamate receptor genes: susceptibility factors in schizophrenia and depressive disorders? |
| Q28654799 | Humanized Foxp2 accelerates learning by enhancing transitions from declarative to procedural performance |
| Q79773008 | In vivo CREB phosphorylation mediated by dopamine and NMDA receptor activation in mouse hippocampus and caudate nucleus |
| Q43691195 | Increased blood pressure and loss of anp-induced natriuresis in mice lacking DARPP-32 gene |
| Q28539599 | Individual differences in ethanol locomotor sensitization are associated with dopamine D1 receptor intra-cellular signaling of DARPP-32 in the nucleus accumbens |
| Q33915563 | Induction of striatal pre- and postsynaptic damage by methamphetamine requires the dopamine receptors |
| Q52676144 | Inhibition of phosphodiesterases as a strategy to achieve neuroprotection in Huntington's disease. |
| Q73318356 | Interaction between dopamine and glutamate receptors following treatment with NMDA receptor antagonists |
| Q33695790 | Ionotropic glutamate receptors |
| Q64230045 | Kinase and Phosphatase Engagement Is Dissociated Between Memory Formation and Extinction |
| Q24323196 | LRRK2 regulates synaptogenesis and dopamine receptor activation through modulation of PKA activity |
| Q33825588 | Localization of dopamine- and cAMP-regulated phosphoprotein-32 and inhibitor-1 in area 9 of Macaca mulatta prefrontal cortex |
| Q29395088 | Mechanisms Underlying Differential D1 versus D2 Dopamine Receptor Regulation of Inhibition in Prefrontal Cortex |
| Q33631775 | Minireview: Tipping the balance: ligand-independent activation of steroid receptors |
| Q28584004 | Modulation of AMPA receptors by cAMP-dependent protein kinase in preBötzinger complex inspiratory neurons regulates respiratory rhythm in the rat |
| Q38358456 | Modulation of excitatory neurotransmission by neuronal/glial signalling molecules: interplay between purinergic and glutamatergic systems |
| Q34431923 | Modulation of ionotropic glutamate receptor channels |
| Q26830654 | Modulation of the glutamatergic transmission by Dopamine: a focus on Parkinson, Huntington and Addiction diseases |
| Q30762316 | Modulation of type 1 inositol (1,4,5)-trisphosphate receptor function by protein kinase a and protein phosphatase 1alpha. |
| Q35153745 | N-methyl-D-aspartate glutamate receptors and alcoholism: reward, dependence, treatment, and vulnerability |
| Q28205016 | NMDA receptor antagonist effects, cortical glutamatergic function, and schizophrenia: toward a paradigm shift in medication development |
| Q36766306 | NMDA receptor-mediated extracellular adenosine accumulation is blocked by phosphatase 1/2A inhibitors. |
| Q33989361 | NMDA receptors in the basal ganglia |
| Q44042111 | NMDA receptors lose their inhibitions |
| Q38918291 | Nanotherapeutic approach for opiate addiction using DARPP-32 gene silencing in an animal model of opiate addiction. |
| Q23913649 | Nerve agent exposure elicits site-specific changes in protein phosphorylation in mouse brain |
| Q34593081 | Neurobehavioral and immunological consequences of prenatal immune activation in rats. Influence of antipsychotics. |
| Q35049891 | Neuroprotective effect of acid-sensing ion channel inhibitor psalmotoxin-1 after hypoxia-ischemia in newborn piglet striatum |
| Q27023378 | Noradrenergic regulation of fear and drug-associated memory reconsolidation |
| Q26849614 | Novel NMDA receptor modulators: an update |
| Q28569506 | Novel alternative splice variants of rat phosphodiesterase 7B showing unique tissue-specific expression and phosphorylation |
| Q40855014 | Novel regulation of p38gamma by dopamine D2 receptors during hypoxia |
| Q37221338 | PSD-95 uncouples dopamine-glutamate interaction in the D1/PSD-95/NMDA receptor complex |
| Q33589580 | Persistent cognitive dysfunction after traumatic brain injury: A dopamine hypothesis |
| Q27006437 | Pharmacology of cognitive enhancers for exposure-based therapy of fear, anxiety and trauma-related disorders |
| Q28588029 | Phosphodiesterase 1B knock-out mice exhibit exaggerated locomotor hyperactivity and DARPP-32 phosphorylation in response to dopamine agonists and display impaired spatial learning |
| Q42845671 | Phosphorylation of huntingtin at Ser421 in YAC128 neurons is associated with protection of YAC128 neurons from NMDA-mediated excitotoxicity and is modulated by PP1 and PP2A. |
| Q28565058 | Phosphorylation of spinophilin modulates its interaction with actin filaments |
| Q27320943 | Phosphorylation of the AMPA receptor GluA1 subunit regulates memory load capacity |
| Q46598656 | Physiological role for casein kinase 1 in glutamatergic synaptic transmission. |
| Q47270899 | Potential for therapeutic targeting of AKAP signaling complexes in nervous system disorders |
| Q28575970 | Potentiation of NMDA receptor currents by dopamine D1 receptors in prefrontal cortex |
| Q43805338 | Prenatal exposure to cocaine disrupts D1A dopamine receptor function via selective inhibition of protein phosphatase 1 pathway in rabbit frontal cortex. |
| Q46987195 | Protein kinase A regulates calcium permeability of NMDA receptors. |
| Q52168469 | Protein phosphatase-1 regulation in the induction of long-term potentiation: heterogeneous molecular mechanisms. |
| Q36211464 | Psychostimulants, madness, memory... and RGS proteins? |
| Q27006067 | Recent progress in understanding subtype specific regulation of NMDA receptors by G Protein Coupled Receptors (GPCRs) |
| Q44257112 | Receptor subtype-specific modulation by dopamine of glutamatergic responses in striatal medium spiny neurons. |
| Q34693215 | Reduced threshold for induction of LTP by activation of dopamine D1/D5 receptors at hippocampal CA1-subiculum synapses |
| Q36301741 | Regulated internalization of NMDA receptors drives PKD1-mediated suppression of the activity of residual cell-surface NMDA receptors. |
| Q34273323 | Regulation of NMDA Receptors by Dopamine D4Signaling in Prefrontal Cortex |
| Q36408077 | Regulation of NMDA receptor Ca2+ signalling and synaptic plasticity |
| Q58112094 | Regulation of phosphorylation of the GluR1 AMPA receptor in the neostriatum by dopamine and psychostimulants in vivo |
| Q46814176 | Regulation of spinophilin Ser94 phosphorylation in neostriatal neurons involves both DARPP-32-dependent and independent pathways |
| Q35747469 | Repeated ketamine administration alters N-methyl-D-aspartic acid receptor subunit gene expression: implication of genetic vulnerability for ketamine abuse and ketamine psychosis in humans |
| Q28394979 | Review: Modulation of striatal neuron activity by cyclic nucleotide signaling and phosphodiesterase inhibition |
| Q36499757 | Role of altered structure and function of NMDA receptors in development of alcohol dependence |
| Q43624965 | Role of convergent activation of glutamatergic and dopaminergic systems in the nucleus accumbens in the development of methamphetamine psychosis and dependence |
| Q92913091 | Role of striatal ΔFosB in l-Dopa-induced dyskinesias of parkinsonian nonhuman primates |
| Q43832590 | Sensitization of glutamate release and N-methyl-D-aspartate receptor response by transient dopamine pretreatment in prefrontal cortex of rats |
| Q42928981 | Sigma receptor ligand 4-phenyl-1-(4-phenylbutyl)-piperidine modulates neuronal nitric oxide synthase/postsynaptic density-95 coupling mechanisms and protects against neonatal ischemic degeneration of striatal neurons |
| Q34492856 | Signaling complexes: junctions on the intracellular information super highway |
| Q35144764 | Signaling molecules and receptor transduction cascades that regulate NMDA receptor-mediated synaptic transmission |
| Q34154154 | Signaling pathways controlling the phosphorylation state of WAVE1, a regulator of actin polymerization |
| Q28513720 | Spinophilin regulates the formation and function of dendritic spines |
| Q39751022 | Subcellular distribution of spinophilin immunolabeling in primate prefrontal cortex: localization to and within dendritic spines |
| Q58765350 | Sucrose Abstinence and Environmental Enrichment Effects on Mesocorticolimbic DARPP32 in Rats |
| Q73704522 | Synergistically interacting dopamine D1 and NMDA receptors mediate nonvesicular transporter-dependent GABA release from rat striatal medium spiny neurons |
| Q35720254 | Targeting Dopamine in Acute Traumatic Brain Injury |
| Q64980739 | The Beneficial Effect of Acute Exercise on Motor Memory Consolidation is Modulated by Dopaminergic Gene Profile. |
| Q42491030 | The Dopamine/D1 receptor mediates the phosphorylation and inactivation of the protein tyrosine phosphatase STEP via a PKA-dependent pathway. |
| Q46876545 | The Down syndrome critical region protein RCAN1 regulates long-term potentiation and memory via inhibition of phosphatase signaling |
| Q42496164 | The cortico-basal ganglia-thalamocortical circuit with synaptic plasticity. I. Modification rules for excitatory and inhibitory synapses in the striatum |
| Q34217470 | The neuregulin signaling pathway and schizophrenia: From genes to synapses and neural circuits |
| Q34378869 | The neurobiology of alcohol consumption and alcoholism: an integrative history |
| Q34100272 | The neurobiology of slow synaptic transmission |
| Q64928904 | The potential roles of dopamine in traumatic brain injury: a preclinical and clinical update. |
| Q35908686 | The role of DARPP-32 in the actions of drugs of abuse |
| Q28580096 | Yotiao protein, a ligand for the NMDA receptor, binds and targets cAMP-dependent protein kinase II(1) |
Search more.